서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Publisher

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 40 of 52

Issue DateTitle / Author(s) / CitationFileAltmetrics
2003-12
Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury
DOI
2007-12
Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival

Yun, Young Ho; Park, Sang Min; Noh, Dong Young; Nam, Seok Jin; Ahn, Se Hyun; Park, Byeong Woo; Lee, Eun Sook

Breast Cancer Research and Treatment, Vol.106 No.2, pp.245-253

DOI
2008-03
Association of clinical experiences with patient-reported outcomes among breast cancer surgery patients: breast cancer quality care study
DOI
2008-03
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
DOI
2009-03
Weight changes after adjuvant treatment in Korean women with early breast cancer

Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok

Breast Cancer Research and Treatment, Vol.114 No.1, pp.147-153

DOI
2009-04
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)

Lee, Sang Gyu; Jee, Young Geon; Chung, Hyun Chul; Kim, Sung-Bae; Ro, Jungsil; Im, Young-Hyuck; Im, Seock-Ah; Seo, Jae Hong

Breast Cancer Research and Treatment, Vol.114 No.3, pp.589-595

DOI
2009-07
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
DOI
2011-01
High serum TGF-alpha predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer
DOI
2011-01
Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)
DOI
2011-04
The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma
DOI
2011-07
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
DOI
2011-12
Phase II study of sunitinib as second-line treatment for advanced gastric cancer
DOI
2012-01
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment
DOI
2012-04
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01
DOI
2012-05
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
DOI
2012-06
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
DOI
2012-08
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy Distinct patterns of response according to ER expression
DOI
2012-08
Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer

Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue

Investigational New Drugs, Vol.30 No.4, pp.1404-1412

DOI
2012-12
Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group

Park, S. H.; Ryu, M. H.; Ryoo, B. Y.; Im, S. A.; Kwon, H. C.; Lee, S. S.; Park, S. R.; Kang, B. Y.; Kang, Y. K.

Investigational New Drugs, Vol.30 No.6, pp.2377-2383

DOI
2012-12
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines
DOI
2013-09
Effects of porous beta-tricalcium phosphate-based ceramics used as an E-coli-derived rhBMP-2 carrier for bone regeneration

Lee, Jae Hyup; Ryu, Mi Young; Baek, Hae-Ri; Lee, Kyung Mee; Seo, Jun-Hyuk; Lee, Hyun-Kyung; Ryu, Hyun-Seung

Journal of Materials Science: Materials in Medicine, Vol.24 No.9, pp.2117-2127

DOI
2013-12
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
DOI
2014-08
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial
DOI
2015-07
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)
DOI
2016-02
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer
DOI
2016-07
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
DOI
2017-09
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
DOI
2017-11
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017)
DOI
2017-12
The significance of frailty in the relationship between socioeconomic status and health-related quality of life in the Korean community-dwelling elderly population: mediation analysis with bootstrapping

Kim, Ho-Joong; Park, Saejong; Park, Soo-Hyun; Heo, Young Woo; Chang, Bong-Soon; Lee, Choon-Ki; Yeom, Jin S.

Quality of Life Research, Vol.26 No.12, pp.3323-3330

DOI
2018-12
Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy

Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah

Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626

DOI
2019-05
Prognostic effects of abnormal DNA damage response protein expression in breast cancer
DOI
2019-07
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients
DOI
2019-10
Treating HR+/HER2-breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
DOI
2019-11
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
DOI
2020-03
Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs

Yoon, Chang Ho; Lee, Hyun Ju; Park, Hye Youn; Kim, Hyungsuk; Kim, Mee Kum; Jeoung, Jin Wook; Oh, Joo Youn

International Ophthalmology, Vol.40 No.3, pp.547-552

DOI
2020-07
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial
DOI
2020-12
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
DOI
2021-04
New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)
DOI
2021-07
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES
DOI
2021-09
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer
DOI
1 2